Chronic systemic inflammation, characteristic of IBD, may contribute to hepatic lipid accumulation through inflammatory cytokines such as tumor necrosis factor-alpha and interleukin-6, which interfere with insulin signaling and promote hepatic steatosis [5]. This evidence concerns the gene INS and inflammatory bowel disease.